Content about Epinephrine autoinjector

April 25, 2013
Mylan marks 25th anniversary of EpiPen's approval by giving it away for free

Mylan Specialty announced Thursday the introduction of a "$0 Co-Pay Offer" on a product used to treat severe allergic reactions.

BASKING RIDGE, N.J. — Mylan Specialty announced Thursday the introduction of a "$0 Co-Pay Offer" on a product used to treat severe allergic reactions.

The drug maker is offering a co-pay card to patients with or without insurance for the EpiPen in recognition of the 25th anniversary of its approval by the Food and Drug Administration. The co-pay card is available online at EpiPen.com, and the offer will expire on Dec. 31.

April 22, 2013
Allermates launching EpiPen, Auvi-Q and asthma inhaler carrying cases

Allermates today announced it is introducing EpiPen, Auvi-Q and asthma inhaler carrying cases.

NANUET, N.Y. — Allermates today announced it is introducing EpiPen, Auvi-Q and asthma inhaler carrying cases.

The cases come in colorful kid-friendly designs and include AllerMates characters. Each case comes with an emergency contact and medication information card. The EpiPen carrying case is insulated, and comes with an epinephrine auto-injector user guide. The cases, like all AllerMates products, are nickel-, lead-, latex-, BPA- and phthalate-free.

February 25, 2013
Mom's creation helps prevent allergy-related ER trips

It's another innovative, yet simple, "Made by Mom" product in the pediatric section. Iris Shamus, the mom and entrepreneur behind AllerMates, developed a line of fun characters that kids won't have a problem wearing and will alert caregivers to specific food allergies.

It's another innovative, yet simple, "Made by Mom" product in the pediatric section. Iris Shamus, the mom and entrepreneur behind AllerMates, developed a line of fun characters that kids won't have a problem wearing and will alert caregivers to specific food allergies.

February 20, 2013
Mylan distributes EpiPens to thousands of schools

A division of drug maker Mylan has distributed auto-injectors of an emergency drug used for severe allergic reactions to schools nationwide.

BASKING RIDGE, N.J. — A division of drug maker Mylan has distributed autoinjectors of an emergency drug used for severe allergic reactions to schools nationwide.

Mylan Specialty said Wednesday that since its August 2012 launch of the EpiPen4Schools program, thousands of schools around the country had elected to participate and receive free EpiPen and EpiPen Jr (epinephrine) auto-injectors. The program was launched to help schools have improved access to epinephrine in the event that a person experiences a life-threatening allergic reaction, also known as anaphylaxis.

January 29, 2013
Sanofi's Auvi-Q epinephrine injection now available

Sanofi announced today that Auvi-Q (epinephrine injection, USP) is now available in U.S. retail pharmacies nationwide with a prescription from a healthcare provider.

BRIDGEWATER, N.J. — Sanofi announced today that Auvi-Q (epinephrine injection, USP) is now available in U.S. retail pharmacies nationwide with a prescription from a healthcare provider.

 

September 26, 2012
Mylan Specialty hires 'Modern Family' star for anaphylaxis campaign

Mylan Specialty has hired a star of a popular TV series as a celebrity spokeswoman for a campaign designed to draw attention to severe allergic reactions.

BASKING RIDGE, N.J. — Mylan Specialty has hired a star of a popular TV series as a celebrity spokeswoman for a campaign designed to draw attention to severe allergic reactions.

August 14, 2012
Mylan launches free EpiPen program

Drug maker Mylan will pass out free EpiPen injectors to children in schools, the company said Tuesday.

BASKING RIDGE, N.J. — Drug maker Mylan will pass out free EpiPen injectors to children in schools, the company said Tuesday.

Mylan Specialty, the Mylan unit that makes the EpiPen (epinephrine), announced the launch of the EpiPen4Schools program. The program offers four free EpiPen or EpiPen Jr. injectors to public and private school students in kindergarten, elementary, middle and high school, who have valid prescriptions.

August 1, 2012
Mylan, Pittsburgh Pirates to sponsor allergy-awareness event at Aug. 10 game

"Buy me some peanuts and Cracker Jacks," goes the line from the famous baseball anthem. For some people, however, that innocuous lyric is a ticket to the hospital, or worse.

PITTSBURGH — "Buy me some peanuts and Cracker Jacks," goes the line from the famous baseball anthem. For some people, however, that innocuous lyric is a ticket to the hospital, or worse.

May 14, 2012
Mylan marks Food Allergy Awareness Week

A company that makes an emergency treatment for severe allergic reactions is marking the 15th annual Food Allergy Awareness Week.

BASKING RIDGE, N.J. — A company that makes an emergency treatment for severe allergic reactions is marking the 15th annual Food Allergy Awareness Week.

Mylan Specialty, a division of drug maker Mylan, said it would support various initiatives to raise awareness of life-threatening food allergies during the special week, which started Sunday and ends Saturday. Mylan Specialty is the maker of EpiPen (epinephrine), used to treat anaphylaxis, a severe allergic reaction that can occur quickly and without warning.

April 27, 2012
Mylan, Pfizer, Teva reach deal over generic version of EpiPen

Two companies have settled with Teva over the latter's efforts to launch a generic version of an emergency treatment for allergic reactions.

NEW YORK — Two companies have settled with Teva over the latter's efforts to launch a generic version of an emergency treatment for allergic reactions.

Under the agreement, involving Mylan and Pfizer's Meridian Medical Technologies subsidiary, Teva will be allowed to launch a generic version of EpiPen (epinephrine) auto-injector in June 2015, assuming it wins approval from the Food and Drug Administration. Mylan Specialty markets the EpiPen, which Meridian manufactures.

February 15, 2012
Mylan rebrands Dey Pharma unit

Mylan is changing the name of its branded specialty pharmaceutical business, the company said Wednesday.

PITTSBURGH — Mylan is changing the name of its branded specialty pharmaceutical business, the company said Wednesday.

The drug maker announced that it would change the name of Dey Pharma to Mylan Specialty. Dey makes treatments for respiratory diseases, psychiatric disorders and severe allergic reactions, including the EpiPen (epinephrine).

August 2, 2011
FDA gives tentative approval to Intelliject device

The Food and Drug Administration has given tentative approval to an emergency treatment for severe allergic reactions made by Intelliject, the drug maker said.

RICHMOND, Va. — The Food and Drug Administration has given tentative approval to an emergency treatment for severe allergic reactions made by Intelliject, the drug maker said.

January 20, 2011
Dey Pharma launches MyEpiPen app

Mylan subsidiary Dey Pharma has launched a mobile application for patients at risk of severe allergic reactions, which is tied to its EpiPen product.

BASKING RIDGE, N.J. — Mylan subsidiary Dey Pharma has launched a mobile application for patients at risk of severe allergic reactions, which is tied to its EpiPen product.

The MyEpiPen app is available for the Apple iPhone, iPod Touch and iPad, and allows individuals, parents, guardians and others to create and share profiles of severe allergies with friends, family, teachers, school nurses, babysitters and others. Other features include an instructional video, user guide and others.

October 11, 2010
Pfizer to acquire King Pharmaceuticals

Pfizer will buy King Pharmaceuticals for $3.6 billion, Pfizer said Tuesday....

NEW YORK Pfizer will buy King Pharmaceuticals for $3.6 billion, Pfizer said Tuesday.

 

The world’s largest drug maker announced that it had agreed to acquire Bristol, Tenn.-based King for $14.25 per share, which it said was a 40% premium over the Monday closing price of King’s stock.

 

 

February 24, 2010
Mylan reports surge in 2009 sales

Mylan had profits of $93.5 million in 2009, the generic drug maker announced Thursday in...